Skip to main content

Corporate insider profile

Octavio Espinoza Insider Trades

Octavio Espinoza has reported no open-market purchases on SEC Form 4 and is a net seller of $9,241,229 across 1 company. The most recent open-market transaction was reported on Aug 12, 2026. Source: SEC Form 4 filings.

Latest reported as Chief Financial Officer of LIGAND PHARMACEUTICALS INC (LGND).

SEC-reported filing activity is provided for research purposes and is not investment advice.

Purchase filings
0
Reported companies
1
Net open-market value
-$9,241,228.67
Latest transaction
Aug 12, 2026

Affiliated corporations

Reported company relationships

Transaction history

Open-market Transactions

Open-market insider purchase and sale transactions
DateCompanyRoleTypeSharesPriceTotal value
Aug 12, 2026LIGAND PHARMACEUTICALS INC (LGND)Chief Financial OfficerSale31,641$292.07$9,241,229

Common questions

Octavio Espinoza insider trading FAQ

Is Octavio Espinoza buying or selling stock?
Across all SEC Form 4 open-market filings on record, Octavio Espinoza is a net seller of $9,241,229, with no open-market purchases reported. The latest transaction was reported on Aug 12, 2026.
Which companies does Octavio Espinoza report insider trades for?
Octavio Espinoza has reported open-market trades in LIGAND PHARMACEUTICALS INC (LGND). The latest SEC-reported relationship is Chief Financial Officer of LIGAND PHARMACEUTICALS INC (LGND).
Where does Octavio Espinoza's insider trading data come from?
Watch Insiders reads the SEC Form 4 filings submitted to EDGAR under reporting owner CIK 1905248, and refreshes this page daily.